We look forward to meeting you at the upcoming Precision Medicine World Congress (PMWC) 2022 in the heart of Silicon Valley, CA. Visit our booth D2818, or Innovation Showcase on Wednesday to learn more about our levitation technology. If you work with cells, whether its single cell applications, cell line development, pdx engraftment, or even CRISPR-modified clones, this technology enables enrichment or recovery of your precious cells.
Booth: #D2818
Meet the new LeviCell EOS System, the newest addition to our portfolio. While the original LeviCell System was designed for low-throughput labs, the new LeviCell EOS enables you to scale up to 16x to accelerate your research. Stop by to see our portfolio and get a demo!
Innovation Showcase – UPDATED TIME
Attend our presentation to learn more about our novel technology that enables viable cell enrichment as well as targeted selection so you can enrich for specific cells of interest. On Wednesday, June 29th from 9:30 – 10:00 am, our Chief Executive Officer, Mr. Martin Pieprzyk, will speak on Maximizing Cellular Insights with Novel Levitation Technology. Learn about the latest success stories, and new single cell data that highlights the importance of cellular enrichment.
Interested in booking a meeting? Submit a request, and our on-site team will be in touch.
About the conference:
PMWC, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization & collaboration in an effort to accelerate the development and spread of precision medicine.
Since 2009, recognized as a vital cornerstone for all constituents of the health care and biotechnology community, PMWC provides an exceptional forum for the exchange of information about the latest advances in technology (e.g. DNA sequencing technology), in clinical implementation (e.g. cancer and beyond), research, and in all aspects related to the regulatory and reimbursement sectors.